Search

Tony Michael Argenbright

Examiner (ID: 16324)

Most Active Art Unit
3402
Art Unit(s)
3402, 3747
Total Applications
2731
Issued Applications
2589
Pending Applications
40
Abandoned Applications
102

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 519459 [patent_doc_number] => 07186414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Compounds and compositions for delivering active agents' [patent_app_type] => utility [patent_app_number] => 11/173075 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10901 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186414.pdf [firstpage_image] =>[orig_patent_app_number] => 11173075 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/173075
Compounds and compositions for delivering active agents Jun 29, 2005 Issued
Array ( [id] => 6926435 [patent_doc_number] => 20050239691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Cross-linked glycopeptide - cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/172303 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17058 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239691.pdf [firstpage_image] =>[orig_patent_app_number] => 11172303 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/172303
Cross-linked glycopeptide—cephalosporin antibiotics Jun 29, 2005 Issued
Array ( [id] => 5880585 [patent_doc_number] => 20060029667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents' [patent_app_type] => utility [patent_app_number] => 11/170652 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28894 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029667.pdf [firstpage_image] =>[orig_patent_app_number] => 11170652 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/170652
Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents Jun 28, 2005 Issued
Array ( [id] => 5793989 [patent_doc_number] => 20060014670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Compositions and methods for the prevention and control of insulin-induced hypoglycemia' [patent_app_type] => utility [patent_app_number] => 11/169825 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31621 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014670.pdf [firstpage_image] =>[orig_patent_app_number] => 11169825 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/169825
Compositions and methods for the prevention and control of insulin-induced hypoglycemia Jun 27, 2005 Issued
Array ( [id] => 5716082 [patent_doc_number] => 20060079445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'CaMKII/calcium channel binding-related compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/155164 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16389 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079445.pdf [firstpage_image] =>[orig_patent_app_number] => 11155164 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/155164
CaMKII/calcium channel binding-related compositions and methods Jun 15, 2005 Abandoned
Array ( [id] => 5297339 [patent_doc_number] => 20090012265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Purification of polymers carrying a lipophilic group' [patent_app_type] => utility [patent_app_number] => 11/597805 [patent_app_country] => US [patent_app_date] => 2005-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8002 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012265.pdf [firstpage_image] =>[orig_patent_app_number] => 11597805 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597805
Purification of polymers carrying a lipophilic group May 29, 2005 Abandoned
Array ( [id] => 5881436 [patent_doc_number] => 20060030519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Composition for reducing blood lipids' [patent_app_type] => utility [patent_app_number] => 11/137498 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2018 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030519.pdf [firstpage_image] =>[orig_patent_app_number] => 11137498 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/137498
Composition for reducing blood lipids May 25, 2005 Abandoned
Array ( [id] => 5210956 [patent_doc_number] => 20070249540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Methods for Inhibiting Proteasome and Heat Shock Protein 90' [patent_app_type] => utility [patent_app_number] => 11/597345 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6557 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249540.pdf [firstpage_image] =>[orig_patent_app_number] => 11597345 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597345
Methods for Inhibiting Proteasome and Heat Shock Protein 90 May 22, 2005 Abandoned
Array ( [id] => 5739002 [patent_doc_number] => 20060009393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Immunogenic epitopes for fibroblast growth factors 5 (FGF-5)' [patent_app_type] => utility [patent_app_number] => 11/134703 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33767 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009393.pdf [firstpage_image] =>[orig_patent_app_number] => 11134703 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/134703
Immunogenic epitopes for fibroblast growth factors 5 (FGF-5) May 18, 2005 Abandoned
Array ( [id] => 196359 [patent_doc_number] => 07638283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Amyloid β protein (globular assembly and uses thereof)' [patent_app_type] => utility [patent_app_number] => 11/130566 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6669 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638283.pdf [firstpage_image] =>[orig_patent_app_number] => 11130566 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/130566
Amyloid β protein (globular assembly and uses thereof) May 15, 2005 Issued
Array ( [id] => 10070697 [patent_doc_number] => 09109041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification' [patent_app_type] => utility [patent_app_number] => 11/579615 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15467 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11579615 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/579615
Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification May 5, 2005 Issued
Array ( [id] => 5769334 [patent_doc_number] => 20060019972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Methods of treating cancer by inhibiting histone gene expression' [patent_app_type] => utility [patent_app_number] => 11/116959 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21567 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019972.pdf [firstpage_image] =>[orig_patent_app_number] => 11116959 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/116959
Methods of treating cancer by inhibiting histone gene expression Apr 26, 2005 Abandoned
Array ( [id] => 6931205 [patent_doc_number] => 20050282240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Method for identifying peptides in a biological sample' [patent_app_type] => utility [patent_app_number] => 11/114629 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9314 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282240.pdf [firstpage_image] =>[orig_patent_app_number] => 11114629 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/114629
Method for identifying peptides in a biological sample Apr 25, 2005 Issued
Array ( [id] => 7069039 [patent_doc_number] => 20050244422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress' [patent_app_type] => utility [patent_app_number] => 11/109161 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13337 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244422.pdf [firstpage_image] =>[orig_patent_app_number] => 11109161 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/109161
Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress Apr 17, 2005 Abandoned
Array ( [id] => 5200218 [patent_doc_number] => 20070299536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Collagen Mimics' [patent_app_type] => utility [patent_app_number] => 10/599926 [patent_app_country] => US [patent_app_date] => 2005-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6186 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299536.pdf [firstpage_image] =>[orig_patent_app_number] => 10599926 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599926
Collagen Mimics Apr 13, 2005 Abandoned
Array ( [id] => 865068 [patent_doc_number] => 07368529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Agent and compositions comprising the same for inhibiting lipases and phospholipases in body fluids, cells and tissues' [patent_app_type] => utility [patent_app_number] => 11/093637 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5055 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368529.pdf [firstpage_image] =>[orig_patent_app_number] => 11093637 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/093637
Agent and compositions comprising the same for inhibiting lipases and phospholipases in body fluids, cells and tissues Mar 29, 2005 Issued
Array ( [id] => 5271067 [patent_doc_number] => 20090074843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Use of epi-hne 1-4' [patent_app_type] => utility [patent_app_number] => 11/547167 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2700 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074843.pdf [firstpage_image] =>[orig_patent_app_number] => 11547167 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547167
Use of epi-hne 1-4 Mar 29, 2005 Abandoned
Array ( [id] => 9427618 [patent_doc_number] => 08703693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment' [patent_app_type] => utility [patent_app_number] => 11/547072 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3553 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11547072 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547072
Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment Mar 29, 2005 Issued
Array ( [id] => 7112243 [patent_doc_number] => 20050209699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor' [patent_app_type] => utility [patent_app_number] => 11/092265 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6816 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209699.pdf [firstpage_image] =>[orig_patent_app_number] => 11092265 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/092265
Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor Mar 28, 2005 Abandoned
Array ( [id] => 5794016 [patent_doc_number] => 20060014697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Pharmaceutical compositions for prevention of overdose or abuse' [patent_app_type] => utility [patent_app_number] => 11/089056 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 144 [patent_figures_cnt] => 144 [patent_no_of_words] => 28143 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014697.pdf [firstpage_image] =>[orig_patent_app_number] => 11089056 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/089056
Pharmaceutical compositions for prevention of overdose or abuse Mar 24, 2005 Abandoned
Menu